drugset / Trial / NCT02785770
A Study To Evaluate The Effect Of PF-04447943 On Qtc Interval In Healthy Adult Subjects
RandomizedCrossoverTriple-blindBasic science
Summary
This is a study designed to ascertain the effect of PF-04447943 on QT interval in healthy adult subjects. This is conducted as part of standard drug development.
Timeline
- Start
- 2016-06-29
- Primary completion
- 2016-10-20
- Completion
- 2016-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EDELINONTRINE | Small molecule | 25 mg | Oral |
| Subject | EDELINONTRINE | Small molecule | 100 mg | Oral |
| Comparator | Moxifloxacin | Small molecule | 400 mg | Oral |
Indications
No indication recorded.